Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Just spotted something interesting while digging through largecap index holdings. The Federated Hermes MDT Large Cap Value ETF (FLCV) is showing solid insider confidence right now - about 10.1% of its weighted holdings have seen insider purchases in the last six months. That's a pretty decent signal.
What caught my eye was Prudential Financial (PRU), which is the #11 position in this largecap fund at $1.2M worth. Three insiders have been buying there recently. Jacques Chappuis (EVP) grabbed 1,000 shares at $100.97 back in early February, then two directors followed - Joseph Wolk picked up 400 shares around $105, and Thomas Stoddard took 250 shares at $102.97. Not huge amounts individually, but consistent buying across the board.
Another name showing similar insider activity is DENTSPLY SIRONA (XRAY), though it's much smaller in the largecap index at position #107. Two directors have been accumulating. Leslie Varon bought 9,337 shares at $10.71 in November, and Gregory Lucier made a bigger move with 50,000 shares at $14.15 in early March. That's a pretty meaningful position for a director to take.
When you see multiple insiders buying at different price points across a largecap portfolio like this, it usually means they're seeing value at current levels. The consistency across these holdings suggests the fund's strategy is resonating with people who actually know the companies. Worth keeping an eye on.